FMTC
VRTX icon

Farmers & Merchants Trust Company’s Vertex Pharmaceuticals VRTX Stock Holding History

Farmers & Merchants Trust Company’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-484
Closed -$215K – 221
2025
Q2 		$215K Buy
484
+58
+14% +$26.7K 0.05% 202
2025
Q1 		$207K Buy
+426
New +$199K 0.05% 184

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Farmers & Merchants Trust Company's VRTX Position: Q3 2025 in Review

Farmers & Merchants Trust Company sold out of Vertex Pharmaceuticals (VRTX) in Q3 2025, closing a stake of 484 shares — an estimated $215K sold.

Farmers & Merchants Trust Company first reported a position in VRTX in Q1 2025 and held it in 2 quarters. The position peaked at $215K in Q2 2025. 1,520 funds tracked by Wall St. Rank hold VRTX as of Q3 2025.

  • Farmers & Merchants Trust Company reported no remaining Vertex Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Farmers & Merchants Trust Company sold 484 Vertex Pharmaceuticals shares in Q3 2025, an estimated $215K.
  • Farmers & Merchants Trust Company first reported a position in Vertex Pharmaceuticals in Q1 2025 and held it in 2 quarters.
  • Farmers & Merchants Trust Company's Vertex Pharmaceuticals position peaked at $215K in Q2 2025.
  • 1,520 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2025.

Based on Farmers & Merchants Trust Company's 13F filing for Q3 2025, filed 27 Oct 2025.